MannKind Corp (MNKD)
NASDAQ NMS - GLOBAL MARKET · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
No company overview is available for MannKind Corp yet.
Peers in Biotechnology
All in industry →Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.
Recent press releases
April 2026
MANNKIND CORP — ARS Filing
# 📄 What This Document Is This is MannKind Corp's **Annual Report to Shareholders (ARS)**. Think of it as the company's yearly "report card." It’s a comprehensive summary of everything that happened in the past year—financial results, business updates, challenges, and plans for the future. It's des
MANNKIND CORP — DEF 14A Filing
# 🧾 What This Document Is — And Why You Got It This is MannKind's **definitive proxy statement (DEF 14A)**. Think of it as the official "meeting agenda" and information packet for shareholders ahead of the annual meeting. Its main jobs are to give you the details you need to vote on company busines
SEC filings
All filings →Insider trades
All insider trades →MannKind Corp has no reported insider trades in the last 90 days.